Aspirin therapy can extend the life of colorectal cancer patients whose tumors carry a mutation in a key gene, but has no effect on patients who lack the mutation, Dana-Farber Cancer Institute scientists report in the Oct. 25 issue of the New England Journal of Medicine.
View the original article here: Gene Mutation Identifies Colorectal Cancer Patients Who Live Longer With … – Science Daily (press release)